ProPublica

Journalism in the Public Interest

Cancel

Prescriber Checkup

At A Glance: This Prescriber in 2012

Internal Medicine

Self-Reported Primary Specialty

See Other Prescribers With This Specialty in This State »

9,114Medicare Part D Prescriptions Filled, Including Refills

Rank: 135 out of 1006

$598K Total Retail Price of All Prescriptions

Rank: 156 out of 1006

465 Patients Receiving at Least One Drug in Part D
91%Patients 65 Years and Older
41% Subsidized Claims for Low-Income Patients

How Does This Prescriber Compare to Peers?

In the same specialty and state. Caveats »

Drugs That Present Special Risks
Costs of Prescribing
Higher avg Average for
this specialty
in Connecticut
Lower avg

Schedule Two
Controlled Substances

4% of this provider’s 465 patients filled at least one prescription for a schedule two drug, compared to an average of 4%.

Schedule Three
Controlled Substances

N/A

Risky Drugs to Seniors

0% of this provider’s 8,760 prescriptions for patients 65 and older were for "potentially dangerous" drugs, compared to an average of 1%.

Brand Name Drugs

26% of this provider’s prescriptions were for brand-name drugs, compared to an average of 29%.

Prescription Price

$66 was the average price of a prescription from this provider, compared to $71 among peers.

Prescriptions per Patient

20 is the average number of prescriptions (including refills) per patient, compared to an average of 18.


Another View

This chart shows a different comparison of all providers in this specialty based on their mix of drugs and volume. Providers are grouped by similarity; those least like their peers are farthest to the right. Hover over the bars to see names of other prescribers.

← Prescribers more like their peers Prescribers less like their peers →
KEY: How to read this
chart

Fewer Prescribers
More Prescribers

This Prescriber
Hover to see more prescribers

This Prescriber's Drugs

The table below list this provider’s drugs, the number of prescriptions and how many went to seniors. Drugs are ranked by volume and compared with the rank for all providers in the same specialty and state.

Click to Filter by Category

Clear Filter


S2

A schedule two drug. More » Schedule two drugs have a high potential for abuse and severe dependence, according to the Drug Enforcement Administration.

S3

A schedule three drug. More » Schedule three drugs have potential for abuse and dependence, according to the Drug Enforcement Administration.

A

An antipsychotic drug. More » Antipsychotics are frequently given to dementia patients, though it increases their risk of death.

R

A risky drug for seniors. More » The American Geriatrics Society has said this drug is "potentially dangerous" for seniors and might be inappropriate.

10

This provider is among the top 10 prescribers of
this drug in the country.

This provider’s prescriptions for this drug were for more days than those of peers. More » Because of this, his or her prescription count may be lower.

This provider’s prescriptions for this drug were for fewer days than those of peers. More » Because of this, his or her prescription count may be higher.

This Drug's Rank
Drug Name Total Prescriptions Filled
Including Refills
Prescriptions
to 65+
Category For this Prescriber For All Prescribers in
This Specialty in Connecticut
LISINOPRIL 378 358 1 3
SIMVASTATIN 370 351 2 1
WARFARIN SODIUM 320 320 3 8
FUROSEMIDE 311 308 4 6
AMLODIPINE BESYLATE 296 294 5 4
HYDROCHLOROTHIAZIDE 283 263 6 11
OMEPRAZOLE 252 240 7 9
ATORVASTATIN CALCIUM 250 242 8 5
METOPROLOL TARTRATE 228 222 9 7
METOPROLOL SUCCINATE 207 188 10 12
LEVOTHYROXINE SODIUM 203 193 11 2
LISINOPRIL-HYDROCHLOROTHIAZIDE 191 191 12 38
ATENOLOL 165 153 13 13
GABAPENTIN 160 145 14 20
LOSARTAN POTASSIUM 143 139 15 22
DIOVAN 142 142 16 16
ALLOPURINOL 138 134 17 31
METFORMIN HCL ER 131 131 18 56
METFORMIN HCL 125 121 19 10
DIOVAN HCT 117 117 20 60
POTASSIUM CHLORIDE 110 110 21 30
ZOLPIDEM TARTRATE 100 100 22 14
TAMSULOSIN HCL 99 99 23 23
DONEPEZIL HCL 95 95 24 17
PANTOPRAZOLE SODIUM 89 89 25 32
CARVEDILOL 87 84 26 36
ESCITALOPRAM OXALATE 76 73 27 27
NEXIUM 75 64 28 28
PREDNISONE 73 72 29 33
DICLOFENAC SODIUM 73 73 29 213
CRESTOR 72 71 31 18
GLIMEPIRIDE 66 65 32 50
ACTOS 65 65 33 89
CLOPIDOGREL 64 62 34 46
DIGOXIN 63 63 35 52
GLIPIZIDE ER 61 59 36 108
PAROXETINE HCL 61 61 36 62
CITALOPRAM HBR 59 59 38 24
MELOXICAM 57 57 39 67
TRAZODONE HCL 56 55 40 21
LANTUS 53 51 41 43
PRAVASTATIN SODIUM 53 48 41 15
MIRTAZAPINE 50 49 43 26
About This Data

ProPublica obtained prescribing data from Medicare’s prescription drug benefit, known as Part D, under the Freedom of Information Act. The data for 2012 includes more than 1.2 billion prescriptions written by nearly 1.5 million doctors, nurses and other providers. This database lists about 382,000 of those providers who wrote 50 or more prescriptions for at least one drug that year. Almost three-fourths went to patients 65 and older; the rest were for disabled patients. Methodology »

Incorrect Info?

If you are a provider and you believe your address is incorrect, check the listing you created on the National Provider Identifier registry. If you change your listing, send a note to drugs@propublica.org and we will update your information. If you have other questions about this data, send a note to drugs@propublica.org.

Caveats
  • No comparisons are shown if 10 or fewer prescribers in the state share this specialty.
  • The list of top drugs includes only those for which this provider wrote 50 or more prescriptions, but all prescriptions are counted in the summary totals at the top.
  • The calculation of “Risky Drugs to Seniors” does not include drugs for which a provider wrote 11 or fewer prescriptions because Medicare redacted the information to protect patient privacy.
  • Comparisons do not take into account the medical conditions of patients. Medications for certain conditions do not have generic alternatives, so patients would receive more expensive brand name drugs.
  • This provider's address and specialty information was last updated on Feb. 7, 2014.
  • Comparisons are based on each provider’s current address, not necessarily where he or she worked during the time period covered in this database.